{"created":"2023-05-15T14:47:38.951032+00:00","id":65332,"links":{},"metadata":{"_buckets":{"deposit":"1b1405e8-fc6e-40c9-bbf3-dc6a35f35fc0"},"_deposit":{"created_by":1,"id":"65332","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"65332"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00065332","sets":["10:29"]},"author_link":["643791","643792","643794","643793"],"item_10005_date_7":{"attribute_name":"発表年月日","attribute_value_mlt":[{"subitem_date_issued_datetime":"2012-04-24","subitem_date_issued_type":"Issued"}]},"item_10005_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"The purpose of this study was to analyze the corelation between gastrointestinal (GI) toxicities and dose-volume factors of carbon ion radiotherapy with concurrent gemcitabine (GEM) in patients with locally advanced pancreatic cancer.\nSeventy patients received carbon ion radiotherapy with a total dose of 43.2-55.2GyE in 12 fractions and concurrent GEM with a dose of 400-1000mg/m2 once a week. The correlation betweeen GI ulcer and dose-volume histogram(DVH) parameters in stomach and duodenum was analyzed. ln patients with Gl ulcer,the total dose irradiated in stomach and duodenum had tendency to increase. There was significant correlation between Gl ulcer and DVH.","subitem_description_type":"Abstract"}]},"item_10005_description_6":{"attribute_name":"会議概要（会議名, 開催地, 会期, 主催者等）","attribute_value_mlt":[{"subitem_description":"平成23年度HIMAC共同利用研究成果発表会","subitem_description_type":"Other"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"篠藤, 誠"}],"nameIdentifiers":[{"nameIdentifier":"643791","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"山田, 滋"}],"nameIdentifiers":[{"nameIdentifier":"643792","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"篠藤 誠","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"643793","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"山田 滋","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"643794","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"conference object","resourceuri":"http://purl.org/coar/resource_type/c_c94f"}]},"item_title":"局所進行膵癌に対するゲムシタビン併用炭素イオン線治療における消化管有害反応のDVH解析","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"局所進行膵癌に対するゲムシタビン併用炭素イオン線治療における消化管有害反応のDVH解析"}]},"item_type_id":"10005","owner":"1","path":["29"],"pubdate":{"attribute_name":"公開日","attribute_value":"2013-11-18"},"publish_date":"2013-11-18","publish_status":"0","recid":"65332","relation_version_is_last":true,"title":["局所進行膵癌に対するゲムシタビン併用炭素イオン線治療における消化管有害反応のDVH解析"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T21:01:20.073791+00:00"}